CD19/CD22 bispecific CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/CD22 bispecific CAR T cells, covering 2024-12-16 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors [Phase 1, Phase 2]